BIOMAT Database Logo BIOMAT Database Logo

[Bretylium tosylate (Darenthin) for cardiac rhythm disorders]. 1970

A Moisan

UI MeSH Term Description Entries
D001949 Bretylium Compounds Benzylammonium compounds with the formula Br-phenyl-CN+R3 that include BRETYLIUM TOSYLATE. Compounds, Bretylium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013610 Tachycardia Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia. Tachyarrhythmia,Tachyarrhythmias,Tachycardias

Related Publications

A Moisan
Hypotensive action of bretylium tosylate (darenthin).
October 1960, American heart journal,
A Moisan
[Bretylium tosylate (darenthin) a new hypotensive agent].
August 1960, Ugeskrift for laeger,
A Moisan
Clinical trial of bretylium tosylate (darenthin) in hypertension.
May 1960, The Central African journal of medicine,
A Moisan
The use of bretylium tosylate (Darenthin) in hypertension.
March 1961, The Medical clinics of North America,
A Moisan
Effect of bretylium tosylate (Darenthin) on pulmonary circulation.
January 1961, Circulation research,
A Moisan
[Bretylium tosylate (Darenthin). Report of an experiment on the clinical significance of bretylium tosylate in the treatment of hypertension].
June 1961, Nederlands tijdschrift voor geneeskunde,
A Moisan
Acquired tolerance to bretylium tosylate ("darenthin") in the treatment of hypertension.
July 1960, The Medical journal of Australia,
A Moisan
A sympathetic blocking agent, bretylium tosylate (Darenthin), in the treatment of hypertension.
February 1961, The Journal of laboratory and clinical medicine,
A Moisan
Bretylium tosylate.
November 1971, American heart journal,
A Moisan
[Use of bretylium tosylate in the prevention of the rhythm disorders of myocardial infarct].
July 1971, Archives des maladies du coeur et des vaisseaux,
Copied contents to your clipboard!